ALEXANDRA AKRA: Open Payments
NPI 1245667559 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 27 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $614 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 1 | $125 |
| Inspire Medical Systems, Inc. | 1 | $122 |
| Astellas Pharma US Inc | 5 | $95 |
| ABBVIE INC. | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Novo Nordisk Inc | 3 | $66 |
| Lilly USA, LLC | 2 | $33 |
| Abbott Laboratories | 1 | $25 |
| Globus Medical, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
Products named: Leqembi, INSPIRE, Veozah, AIRSUPRA, VRAYLAR, JARDIANCE, REXULTI, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
